Cyber Resilience

CVE-2020-27260

Medium

Published: 08 January 2021

Published
08 January 2021
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 5.3 CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
EPSS Score 0.0011 28.7th percentile
Risk Priority 11 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2020-27260 is a medium-severity Injection (CWE-74) vulnerability in Innokasmedical Vital Signs Monitor Vc150 Firmware. Its CVSS base score is 5.3 (Medium).

Operationally, ranked at the 28.7th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages…

more

via multiple expected parameters.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

innokasmedical
vital signs monitor vc150 firmware
≤ 1.7.15

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-74

Developer assessments and testing (including injection-focused techniques) identify improper neutralization of special elements, and the verifiable flaw remediation corrects them pre-deployment.

addresses: CWE-74

Identifies indicators of injection attacks (command, SQL, LDAP, etc.) via anomaly and attack monitoring.

References